SEATTLE – Biomatics Capital Partners has closed on an initial fund of $200 million, with plans to invest in genomics, digital health and data-driven health care technologies. “In the next decade, breakthrough science and technology will fundamentally transform the practice of medicine and delivery of health care,” said Dr. Boris Nikolic, managing director of Biomatics Capital Partners, who previously served as chief advisor for science and technology to Bill Gates. The firm estimates it will invest in 15-20 companies. “By combining the best of science with sound investment practices, we are looking to create extraordinary financial value for our investors and a pathway to better patient outcomes,” said Julie Sunderland, co-managing director at Biomatics.
You are here: / / Biomatics Capital to invest $200M fund into genomics, digital health